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Introduction
Philanthotoxin-433 (PhTX-433, 1; the numerals indicate the number of methylene groups spacing the nitrogens in the polyamine moiety; Figure 1 ) is a toxin found naturally in the venom of the solitary wasp, Philanthus triangulum. [1, 2] PhTX-433 and many of its synthetic analogues have been shown to have non-competitive inhibitory effects at both ionotropic glutamate receptors and nicotinic acetylcholine receptors. [3] [4] [5] [6] In that respect PhTXs are attractive molecules to investigate further given that both of these receptor types are accepted as valid drug targets for a variety of neurodegenerative and other disorders of the central nervous system. [7] The modular butyryl-tyrosylthermospermine composition of 1 has allowed for efficient generation of many synthetic analogues demonstrating the importance of all of these structure segments. [4, 6, [8] [9] [10] [11] PhTXs 1, 2 and an array of other analogues have been shown to produce powerful voltage-dependent inhibition of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) currents suggesting a binding mode with the polyamine inserted deeply within the pore region of the ion channel. [3] This hypothesis is supported by the observation that AMPARs containing the GluA2 subunit with arginine at the "Q/R" site in the selectivity filter of the pore exhibit drastically reduced inhibition by PhTX-343 and other polyamine-containing molecules. [12] In the last two decades advanced methodologies for solidphase synthesis (SPS) of polyamines have been developed, [13] however, no examples of SPS of cyclopropane-containing polyamine derivatives have been reported. The commonly used solution-phase method for obtaining polyamines displaying a cyclopropane moiety is alkylation of mesitylenesulfonamides with mesitylenesulfonates of cyclopropane diols, but this is not readily transferred into an SPS protocol due to the harsh conditions required for deprotonation of the sulfonamide and the risk of cross-linking the resin due to the bifunctional building block. [14] Cyclopropane-trans-1,2-dicarboxylic acid [15] may be readily obtained from the corresponding ethyl diester and the cisanhydride 3-oxabicyclo[3.1.0]hexane-2,4-dione was commercially available, and therefore, we chose an approach involving on-resin reduction of the diamide corresponding to the desired 4,4'-dimethoxytrityl-protected polyamine. [16] In the present work we focus on incoporating unprecedented structural variations of the polyamine moiety present in both 1 and its well-studied close structural analogue, PhTX-343 (2), and examine how these influence the inhibitory effects of the resulting PhTX analogues on a specific subunit, GluA1flop, present in members of the AMPAR subdivision of the ionotropic glutamate receptor family. This subunit is characteristic of a calcium-permeable and polyamine-sensitive subtype of AMPARs, with the flop splice variant (a 38 amino acid region upstream of the fourth transmembrane region) being upregulated in place of the flip splice variant during early development to become dominating in adult CNS. Constraints were introduced in the central region of the polyamine moiety in an attempt to assess the importance of rigidity in this region. This was achieved by solid-phase synthesis incorporating cyclopropane moieties into the polyamine chain to give trans-and cis-analogues with 3-4-3 or 4-4-4 (i.e. PhTX-343-or PhTX-444-like) spacing between the nitrogens (3-6 = trans-343, trans-444, cis-343, cis-444, respectively; Figure 1 ). Analogues 2-6 were tested for inhibitory potency against homomeric rat GluA1flop AMPARs expressed in Xenopus oocytes by measurement of their reduction of currents evoked by stimulation with kainic acid (KA; 100 μM) by using a two-electrode voltage-clamp at a holding potential of -80 mV. Although KA is a weaker agonist of AMPARs it is often used instead of AMPA or L-Glu in these assays to avoid the problem of rapid receptor desensitization. 
Results and Discussion

Solid-phase synthesis of philanthotoxin analogues
First, cyclopropane-trans-1,2-dicarboxylic acid diethyl ester (7) was converted into the corresponding pentafluorophenyl diester 8 (Scheme 1) via alkaline hydrolysis and subsequent transesterification by using pentafluorophenyl trifluoroacetatepyridine (1:1) in DMF. [15, 17] Building blocks 9a and 9b were obtained upon condensation of pentafluorophenyl diester 8 with one equivalent of the appropriate 2-(trimethylsilyl)ethoxycarbonyl (Teoc)-monoprotected diamine.
[16b]
In order to minimize cross-linking of the 2-chlorotrityl chloride resin, it was loaded with the appropriate Teocmonoprotected diamine (Scheme 2). A prolonged reaction time of two days enabled a cost-efficient use of these selectively protected diamines as only 10% excess was required. The resulting resin-bound diamines 10a/10b were then coupled with building blocks 9a/9b to give Teoc-protected diamide intermediates 11a/11b that were subjected to exchange of the Nprotecting group followed by borane reduction to yield the 4,4'-dimethoxytrityl (Dmt)-protected polyamine intermediates 12a/12b. The thus formed secondary amino functionalities were Bocprotected, and then the Dmt group on the terminal primary amine was removed under weakly acidic conditions to give selectively protected resin-bound polyamines 13a/13b. Successive acylation with the activated ester, Fmoc-Tyr( t Bu)-OPfp, Fmoc deprotection, acylation with pentafluorophenyl butanoate, [18] and cleavage from the linker afforded the crude trans-cyclopropane-containing target philanthotoxins that readily were pufied by reversed-phase preparative HPLC to give PhTXs 3 and 4 as the tris(TFA) salts. SPS of the corresponding cis-cyclopropane-containing PhTXs also started from resin-bound diamines 10a/10b, but in this case these were acylated with the cis-anhydride 3-oxabicyclo[3.1.0]-hexane-2,4-dione to give intermediate resins 14a/14b. Elongation with the respective Teoc-monoprotected diamines under DIC/HOBt amide coupling conditions followed by removal of the Teoc group furnished the unprotected diamides 15a/15b. Introduction of the Dmt-protecting group and subsequent borane reduction of the amide fuctionalities gave rise to resins 16a/16b that upon Boc-protection and Dmt removal afforded primary amines 17a/17b that were acylated and cleaved from the resin as described for the trans-analogues to yield PhTXs 5 and 6 as the corresponding tris(TFA) salts upon purification. 
Receptor inhibition by philanthotoxins
PhTX analogues 2-6 were all able to cause potent inhibition of currents evoked by exposure of oocytes to 100 μM KA ( Figure 2 ) with their IC50 values given in Table 1 . The present study is the first to report on PhTX-343 inhibition of homomeric rat GluA1flop channels while previous reports have focused on rat GluA1flip or AMPARs expressed from mRNA extracted from rat brain. We found that the IC50 for GluA1flop inhibition is similar to that for GluA1flip [12] but is about 10-fold higher than that observed for KAactivated channels expressed from rat brain mRNA. [4, 10] The subunit combination of the latter is not known, but presumably it contains other AMPAR subunits that may be more sensitive to PhTX 2. All of the cyclopropane-containing PhTX analogues (3) (4) (5) (6) were significantly more potent inhibitors than 2, with the transconfigured 3 being the most potent; nearly 30-fold more so than the corresponding straight-chain PhTX 2. Table 1 . 
Modelling studies on philanthotoxins
It is well known that the potency of a philanthotoxin analogue is influenced by changes in the length of the polyamine moiety as well as by the number and distribution of the positively charged amino groups as these factors determine the overall shape and electronic properties of the resulting molecule via intramolecular H-bonding. [3, 4, 19, 20] Figure 3. Structures of philanthotoxin analogues 2-6 visualizing the three general conformations that can be adopted: "head and tail" for 2 (A) and 3 (C), "semi-folded" for 4, 5 and 6 (D-F) and "folded" for 2 (B). G) A clearer view of Hbonding (pink lines) between amide oxygens and amine hydrogens in 3 for an HT conformation and in 5 for a SF conformation.
PhTX analogues can adopt three general low-energy structures, "head and tail" (HT; extended), "semi-folded" (SF) and "folded" (F) (as depicted in Figure 3) , depending on whether Hbonding involves the first, second, or third amino group, respectively. The HT structure is believed to be the most active at AMPARs due to previous observations showing that the monocationic analogues are virtually inactive at AMPARs. [4, 14] In terms of general shape mono-cationic analogues are "folded" because they do not possess a "tail" at all. Our modelling studies show that for all compounds the vast majority (99.8%) of low-energy conformations possessed at least one intramolecular H-bond. Ensembles of low-energy conformations obtained for the PhTX analogues studied contained all three types of structures (HT, SF and F) within 3 kcal mol -1 from the apparent energy minimum (0.5-1.0 kcal mol -1 ). To reveal the conformational preferences of the compounds we compared the relative numbers of conformations belonging to the different types within these ensembles. Compound 2 was found to be distributed as 85% HT ( Figure 3A) , 13% SF and 2% F ( Figure 3B ). This was unchanged for 3 so the additional hydrocarbon bulk, which in fact becomes part of the head group and relocating the tyrosyl group ( Figure  3C ), appears to be responsible for the increased potency of 3. This is reminiscent of analogues where short hydrocarbon chains were introduced to the central section of the polyamine moiety resulting in more potent analogues at insect quisqualate sensitive ionotropic glutamate receptors. [9] The cis-analogue of 3 (i.e compound 5) was less potent as the cis arrangement caused the molecule to adopt a greater proportion of SF structure (44%) ( Figure 3D ) at the expense of HT (54%). The cause of this effect is that in the cis form both amino groups occur at the same side of the bulk and rigid cyclopropane ring. While the trans configuration dictates a rather large distance between amino groups (6.2 Å in the lowest-energy structure), the cis configuration results in a significantly smaller distance (4.6 Å). As a result, the probability that the second amino group is involved in intramolecular H-bonding (and thus the structure is semi-folded) is larger for the cis than the trans configuration ( Figure 3G ).
PhTX analogues 4 and 6 showed intermediate potency between 3 and 5 since the additional carbon in the chain between the head group and the first amine functionality allowed for more flexibility and hence a higher proportion of SF structures ( Figure  3 ; E-F). The SF structures for these analogues are likely to be more active because of the longer chain between the second and terminal amine groups (giving it a more HT-like structure).
Conclusion
Introduction of a cyclopropane moiety between the first and second amino groups of PhTX-343 proved beneficial for AMPAR antagonism, but less so for the cis-analogue due to its greater tendency to become semi-folded as inferred by modeling studies. The positive (for trans-analogues) and negative (for cisanalogues) effects of this structural alteration are to some extent obscured by the increased spacing of the amide and the first amine functionality as well as of the second and third amines, such that both PhTX-444 analogues display similar potency.
Experimental Section
General procedures. Unless otherwise stated, starting materials and solvents were purchased from commercial suppliers (H-Tyr( t Bu)-OH from Novabiochem, reagents and solvents from Sigma-Aldrich, Fluka, or Lancaster) and used as received. CH2Cl2 was distilled from P2O5 and stored over 4 Å molecular sieves. THF was distilled from Na/benzophenone immediately before use. 1 H NMR and 13 C NMR spectra were recorded at 400.14 MHz and 100.62 MHz, respectively, on a Bruker AMX 400 spectrometer, or at 300.06 MHz and 75.45 MHz, respectively, on a Varian Mercury Plus spectrometer, using CDCl3 or CD3OD as solvents and tetramethylsilane (TMS) as internal standard. Coupling constants (J values) are given in hertz (Hz), and multiplicities of 1 H NMR signals are reported as follows: s, singlet; d, doublet; t, triplet; q, quartet; p, pentet, sx, sextet; m, mulitplet; br, broad. High-resolution mass spectrometry (HRMS) measurements were performed on a Bruker APEX Qe Fourier transform mass spectrometer equipped with a 9.4 tesla superconducting cryomagnet, and an external electrospray ion source (Apollo II source). The spectra were externally calibrated with an arginine cluster in positive mode. The samples were dissolved in MeOH, introduced into the electrospray ion source using a syringe pump with a flow of 2 L/min. Solid-phase reactions were performed in Teflon filter vessels on a Scansys PLS 4 × 6 Organic Synthesizer equipped with a heating block. Preparative HPLC system consisted of an Agilent 1100 system with 2 preparative pump units, a UV detector, and a Phenomenex Luna C18(2) (5 m) column (25  2.12 cm). Linear elution gradients were composed by mixing solvent A (MeCN-H2O-TFA 5:95:0.1) and B (MeCN-H2O-TFA 95:5:0.1) at a flow rate of 20 mL/min. Analytical HPLC was performed on a Shimadzu system consisting of an SCL-10A VP controller, an SIL-10AD VP autosampler, an LC-10AT VP pump, an SPD-M10A VP diode array detector, and a CTO-10AC VP column oven, using a Phenomenex Luna C18(2) (3) column (150  4.6 mm). The HPLC system was controlled by Class VP 6 software; elution was performed with two different solvent systems (total flow of 0.8 mL/minute). Solvent A = MeCN-H2O-TFA 10:90:0.1 and solvent B = MeCN-H2O-TFA 90:10:0.1; t = 0-5 min 0% B, t = 5-30 min 0-40% B, t = 30-35 min 40-100% B). The purities of target compounds 3-6 were determined (from UV absorption integration at  = 215 nm) and were within the ranges 97-99%.
Dipentafluorophenyl Cyclopropane-trans-1,2-dicarboxylate (8):
Diethyl trans-1,2-cyclopropanedicarboxylate (7, 5.15 g, 27.7 mmol) was subjected to hydrolysis with NaOH (5.16 g, 4.66  27.7 mmol) in H2O-EtOH (2:1, 75 mL) for 4 h at room temperature. The reaction mixture was diluted with H2O (200 mL), and then washed with Et2O (100 mL), which was extracted back with H2O (50 mL). The combined aqueous phases were concentrated to dryness in vacuo. The residue was partially dissolved in EtOAc (100 mL), which then was filtered through a layer of Na2SO4. The filtrate was evaporated to give the crude diacid (2.98 g, 83%). The diacid (1.40 g, 10.8 mmol) was treated with CF3COOPfp (4.64 mL, 2.5  10.8 mmol) and pyridine (2.18 mL, 2.5  10.8 mmol) in dry DMF (15 mL) for 19 h under N2.
The reaction mixture was diluted with EtOAc (250 mL), and then extracted successively with 0.1 M HCl (3  150 mL), saturated aqueous NaHCO3 (3  150 mL), and brine (150 mL). Upon drying (Na2SO4) the solvent was removed to give 8 (4.86 g, 98%). Protected Monoamides (9a/9b) from Dipentafluorophenyl Cyclopropane-trans-1,2-carboxylate: The diPfp ester (1.78 g, 3.85 mmol) was dissolved in dry CH2Cl2 (25 mL), and then the appropriate Teoc-monoprotected diamine (3.85 mmol) and DIPEA (1.34 mL, 2  3.85 mmol) in dry CH2Cl2 (10 mL), were added. After 19 h, the reaction mixture was diluted with EtOAc (150 mL), and then washed with 0.1 M HCl-brine (3:1, 3 × 100 mL), H2O (100 ml), satd NaHCO3-brine (3:1, 3 × 100 mL), and brine (75 mL). The organic layer was dried (Na2SO4) and concd. The residue was dissolved in CH2Cl2 (15 mL) and loaded onto a VLC column (5.5 × 6 cm), which was eluted with hexane and then hexane-Me2CO 20:1 to 4:1. This afforded 9a (1.24 g, 65%) or 9b (1.10 g, 56%). 9a: (20 mL) . After 2 days, the resin was transferred to a 20 mL syringe, and then washed with CH2Cl2 (2 ×15 mL) and subsequently end-capped with CH2Cl2-MeOH-DIPEA (80:15:5, 15 mL, 2 × 10 min). The resin was then washed with CH2Cl2, MeOH, dry CH2Cl2 (each 3×), dried overnight (to give 2.52 g and 2.57 g, respectively of resin-bound Teoc-protected 1,3-propanediamine and 1,4-butanediamine, repectively). Then the Teoc groups were removed by treatment with TBAF (3 equiv) in dry DMF (45 mL; in a round-bottomed flask) at 50 C for 1 h and then at room temperature for 3 h. The resins were then washed with CH2Cl2, MeOH, dry CH2Cl2 (each 3×), dried overnight (to give ~2.0 g, 10a/10b). The loadings were determined to be ~1.8 mmol/g based on the mass gain and coupling with Fmoc-Gly-OH.
SPS of Protected trans-Cyclopropane PhTX-Analogues:
Resinbound diamines (10a/10b, 0.44 mmol) were swelled in dry DMF for 30 min. The solvent was removed by suction, and the resin was treated with a cyclopropane building block (9a or 9b, 2 equiv), HODhBt (1 equiv) and DIPEA (2 equiv) in dry DMF (10 mL/mmol resin). The mixture was shaken for 16 h at room temperature. The resin was drained and then washed with DMF, MeOH, CH2Cl2 and DMF (3 × 12 mL/mmol resin with each solvent). The Teoc group was removed by treatment with TBAF (5 equiv) in DMF (7.5 mL/mmol resin) at 55 C for 15 min. Upon draining and wash with DMF, this deprotection step was repeated. The resin was drained and then washed with DMF, MeOH, and CH2Cl2 (3 ×). Dmt-Cl (6 equiv) in dry CH2Cl2 (9 mL/mmol resin) and DIPEA (6 equiv) were added to the resin. After 3.5 h, the resin was drained and washed with CH2Cl2, CH2Cl2-MeOH-DIPEA (80:15:5), DMF, CH2Cl2, and THF (each 3 ×). The resin was transferred to a 25 mL flask with a minimum of THF, and then 1M BH3•THF in THF (20 equiv) was added. The flask was heated to reflux under N2 in an oil bath (70 C) for 16 h. The resin was transferred back to a teflon reactor using THF. Upon draining, the resin was washed with MeOH (3 ×). Then the resin was treated with piperidine (9 mL/mmol resin) at 60 C for 1.5 h. After washing with MeOH (12 mL/mmol), this decomplexation procedure was repeated twice. The resin was treated with Boc2O (10 equiv) and DIPEA (10 equiv) in dry CH2Cl2 (6 mL/mmol resin) for 16 h followed by draining and wash with DMF, MeOH, DMF, and CH2Cl2 (each 3 ×). Dmt deprotection with 0.1M ClAcOH in CH2Cl2 (14 mL/mmol resin) for 30 min followed by wash with CH2Cl2 was repeated three times. The resin was drained and washed with DMF, MeOH, CH2Cl2, and dry DMF (each 3 ×). The resulting resin was coupled with Fmoc-Tyr( t Bu)-OPfp (3 equiv), HODhBt (1 equiv), and DIPEA (3 equiv) in dry DMF (7 mL/mmol resin) for 16 h. Upon draining, the resin was washed with DMF, MeOH, CH2Cl2, and dry DMF (each 3 ×). Coupling with FmocTyr( t Bu)-OPfp was repeated (due to a positive Kaiser test) using DMF-CH2Cl2 (3:1) as solvent. Fmoc deprotection with 20% piperidine-DMF (11 mL/mmol resin) for 10 min was repeated after a DMF wash. Upon draining, the resin was washed with DMF, MeOH, CH2Cl2, and dry DMF (each 3 ×). The resulting resin was treated with pentafluorophenyl butanoate (3 equiv), HODhBt (1 equiv), and DIPEA (3 equiv) in dry DMF (8 mL/mmol resin) for 16 h. Upon draining, the resin was washed with DMF, MeOH, and CH2Cl2 (each 3 ×). Cleavage of the product from the resin was performed with TFACH2Cl2 (1:1, 9 mL/mmol resin) for 2 h. The filtrate was collected by suction, and the resin eluted further with CH2Cl2 and MeOH (each 2 × 9 mL/mmol resin). The combined filtrates were concentrated, and the residue purified by preparative HPLC (>95% purity): 3 (46 mg) and 4 (115 mg). 52.2, 57.1, 116.2, 117.6, 128.7, 131.1,  157.2, 162.1 SPS of Protected cis-Cyclopropane PhTX-Analogues: Resinbound diamines (10a/10b, 0.55 mmol) were swelled in dry DMF for 30 min. The solvent was removed by suction, and a solution of 3-oxabiclo[3.1.0]hexane-2,4-dione (4 equiv) and DIPEA (2 equiv) in dry DMF (7 mL/mmol resin) was added to the resin. After 16 h, the resin was drained and washed with DMF, MeOH, DMF, and dry CH2Cl2 (each 3 × 12 mL/mmol resin). Then the resin was treated with Teocmonoprotected diamine (4 equiv), HOBt (4 equiv), and DIC (3 equiv) in dry DMF (8 mL/mmol resin) for 16 h. The resin was drained and washed with DMF, MeOH, DMF, and dry CH2Cl2 (each 3 ×). Successive Teoc deprotection, introduction of Dmt protecting groups, borane reduction/decomplexation, and Boc protection were performed as described above for trans-analogues. Upon draining and wash with DMF, MeOH, DMF, and CH2Cl2 (each 3 ×), Dmt groups were removed with 0.1M ClAcOH in CH2Cl2 (11 mL/mmol resin, 4 × 30 min). The resin was drained and washed with DMF, MeOH, CH2Cl2, and dry DMF (each 3 ×). The resulting resin was elongated with the Tyr residue, and subsequently terminated by introduction of the N-butyryl group as described above (using single couplings for 16 h). Cleavage of the product from the resin was performed with TFA-CH2Cl2 (1:1, 7 mL/mmol resin) for 2 h. The crude products were purified by preparative HPLC (>95% purity): 5 (220 mg) and 6 (64 mg). 5: 
